- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02653469
Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy
March 2, 2016 updated by: Jong Hwan Lee, Samsung Medical Center
Pulse Pressure Variation With Augmented Ventilation to Predict Fluid Responsiveness in the Patients Undergoing Open Laparotomy Surgery
Pulse pressure variation (PPV) is a well-known and widely used dynamic preload indicator based on heart-lung interaction to predict fluid responsiveness.
Generally, patients are considered to be fluid-responsive when the PPV value larger than 11-13%.
However, several previous researches demonstrated that there is a zone of uncertainty (grey zone) in PPV.
To predict fluid-responsiveness accurately in the patients with PPV within grey zone (9-13%), the investigators would evaluate the augmented PPV using augmented ventilation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
38
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 135710
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult patients undergoing elective open laparotomy surgery.
Description
Inclusion Criteria:
- Adult patients undergoing elective open laparotomy surgery.
Exclusion Criteria:
- Irregular heart beats,
- cardiac arrhythmia,
- moderate or severe valvular heart disease,
- preoperative left ventriular ejection fraction less than 40%,
- moderate t severe obstructive pulmonary disease,
- preoperative need of inotropics infusion,
- preoperative serum Cr > 1.3ml/dl,
- moderate to severe renal or liver disease,
- acute lung injury or acute lung problem,
- coexisting open chest condition,
- severe bradycardia,
- patients with spontaneous breathing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Augmented ventilation with fluid loading
This is an observational study and as a diagnostic intervention, subjects in the study would receive mechanical ventilation with augmented tidal volume of 12ml/kg for 2min.
Augmented ventilation is performed when the patient's PPV is within grey zone (9-13%).
The investigators perform this procedure to every patients and do not assigh this intervention to the subjects of the study.
Then, 6ml/kg of ballanced crystalloid loading will be infused to every patient.
|
When the patient's PPV is within grey zone, patient's tidal volume is maintained with augmented tidal volume of 12 ml/kg (from normal ventilation of 8ml/kg) for 2min duration.
We record the stroke volume index (SVI) values before and after volume expansion with 6ml/kg of balanced crystalloid
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Augmented PPV (Pulse Pressure Variation) to predict fluid responsiveness
Time Frame: within 2 min from augmented ventilation
|
Augmented ventilation (12ml/kg) will be performed when the participant's PPV is within grey zone (9-13%).
PPV value will be collected automatically by Intelivue philips patient monitor.
Percentage changes in stroke volume index by EV1000 according to fluid loading were used as principal indicators of fluid responsiveness.
Patients were classified as responders or non-responders when increases in SVI were ≥ 10% or <10% after volume loading (crystalloid iv 6ml/kg).
To test the abilities of augmented PPV to predict fluid responsiveness, areas under the receiver operating characteristics (ROC) curves of the responders [area under the curve (AUC) = 0.5: no better than chance, no prediction possible; AUC = 1.0: best possible prediction] will be calculated.
|
within 2 min from augmented ventilation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Conventional baseline PPV to predict fluid responsiveness
Time Frame: when patients PPV in grey zone, before augmented ventilation
|
PPV value will be collected automatically by Intelivue philips patient monitor.
|
when patients PPV in grey zone, before augmented ventilation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
February 1, 2016
Study Registration Dates
First Submitted
October 20, 2015
First Submitted That Met QC Criteria
January 9, 2016
First Posted (Estimate)
January 12, 2016
Study Record Updates
Last Update Posted (Estimate)
March 4, 2016
Last Update Submitted That Met QC Criteria
March 2, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMC 2015-06-015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Neoplasms
-
Peking University Third HospitalRecruiting
-
Tianjin Medical University Cancer Institute and...UnknownAbdominal Infection | Abdominal TumorChina
-
M.D. Anderson Cancer CenterRecruitingIntra-abdominal CancerUnited States
-
National Taiwan University HospitalUnknownSymptomatic Abdominal TumourTaiwan
-
Assiut UniversitySouth Egypt Cancer InstituteCompletedPostoperative Analgesia | Lower Abdominal CancerEgypt
-
Duke UniversityMakerere University; Uganda Cancer InstituteNot yet recruiting
-
Catholic University of the Sacred HeartCompletedAbdominal NeoplasmsUnited States, France, Italy, Japan
-
Assiut UniversityUnknown
-
Mansoura UniversityRecruiting
-
Universidade Cidade de Sao PauloWithdrawnAbdominal CancerBrazil
Clinical Trials on Augmented ventilation
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
University of PittsburghNortheastern University; NSFRecruiting
-
University of Alabama at BirminghamCompletedStroke | Hemiparesis | Walking, DifficultyUnited States
-
Brigham and Women's HospitalWithdrawnPain | Infection | MalignancyUnited States
-
Radboud University Medical CenterCompleted
-
Chinese University of Hong KongNot yet recruiting
-
Wayne State UniversityEnrolling by invitationSpecific Phobia, AnimalUnited States
-
University of VirginiaRecruitingPain, Acute | Vocal Cord Paralysis | Laryngeal Neoplasms | Vocal Fold PolypUnited States
-
University Hospital, Clermont-FerrandActive, not recruitingMyoma;Uterus | Adenomyoma of UterusFrance
-
Universidad Peruana Cayetano HerediaCompletedHospitalized ChildPeru